For the Inventor, By the Inventor

Enter inventor name

Shinji Tonomura

USPTO Granted Patents = 56

Average Co-Inventor Count = 6.1

ph-index = 15

Forward Citations = 743(Granted Patents)

Forward Citations (Not Self Cited) = 654(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Tokyo, JA (1976 - 1978)
Machida, JP (1981)
Tokyo, JP (1978 - 1987)
Kanagawa, JP (1988)

Company Filing History:

Mitsubishi Chemical Industries Limited

Shosuke Okamoto

39 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 1976-1988

Loading Chart...

Areas of Expertise:

Arginine Derivatives

Pharmaceutical Salts

Arylsulfonyl Compounds

Naphthalenesulfonyl Compounds

Alkoxynaphthylsulfonyl Compounds

2-Substituted Compounds

Pharmaceutically Active Compounds

Omega-Aminoalkoxy Compounds

Diphenylmethanes

Sulfonyl-Argininamides

Pharmaceutical Applications

Active Pharmaceutical Ingredients

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4764618 - Arginine derivatives and pharmaceutically acceptable acid addition salts (1988-08-16),

2. 4670420 - N.sup.2 -dansyl-L-arginine derivatives, and the pharmaceutically (1987-06-02),

3. 4562211 - Pharmaceutically active 2-substituted-1-(omega-aminoalkoxy)benzenes (1985-12-31),

4. 4258192 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1981-03-24),

5. 4227006 - N.sup.2 -Dansyl-L-arginine derivatives, and the pharmaceutically (1980-10-07),

6. 4201863 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1980-05-06),

7. 4173630 - N.sup.2 Arylsulfonyl-L-argininamides and the pharmaceutically acceptable (1979-11-06),

8. 4168307 - N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives, and the (1979-09-18),

9. 4154828 - N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives, and the (1979-05-15),

10. 4140681 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1979-02-20),

11. 4139529 - N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives and the (1979-02-13),

12. 4133880 - N.sup.2 -Substituted-L-arginine derivatives and the pharmaceutically (1979-01-09),

13. 4131673 - N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically (1978-12-26),

14. 4125619 - N.sup.2 -naphthalenesulfonyl-L-arginine derivatives and the (1978-11-14),

15. 4125604 - N2-Arylsulfonyl-L-argininamides and the pharmaceutically acceptable (1978-11-14),

Title: Innovator Spotlight: Shinji Tonomura - Pioneering Inventor from Tokyo

Introduction:

Shinji Tonomura, a distinguished inventor hailing from Tokyo, Japan, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 56 patents. His innovative work in developing novel arginine derivatives has revolutionized the realm of pancreatitis remedies.

Latest Patents:

Tonomura's latest patents showcase his expertise in creating arginine derivatives with trypsin-inhibiting activity, essential for treating pancreatitis. These derivatives, along with their pharmaceutically acceptable salts, have demonstrated promising results in providing effective remedies for pancreatic disorders.

Career Highlights:

Having worked at Mitsubishi Chemical Industries Limited and other reputable organizations, Tonomura has honed his skills and knowledge in pharmaceutical research and development. His career highlights include a track record of breakthrough innovations that have garnered attention in the scientific community.

Collaborations:

Throughout his career, Tonomura has collaborated with esteemed professionals in the field, such as Ryoji Kikumoto and Shosuke Okamoto. These collaborations have fueled his inventive spirit, leading to the successful creation of impactful pharmaceutical solutions.

Conclusion:

In conclusion, Shinji Tonomura stands out as a visionary inventor whose dedication to advancing pharmaceutical science has resulted in numerous groundbreaking patents. His contributions to the field of pancreatitis treatment underscore his commitment to innovation and improving healthcare outcomes. Tonomura's innovative spirit continues to inspire aspiring inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…